MMP9 and breast carcinoma: By interrogating a large meta-analysis of published breast cancer microarray datasets [35], we found that MMP9 expression was most highly elevated in basal-like breast cancers, as classified according to the intrinsic subtypes of Hu et al. [36] (Fig. 6A) or the PAM50 subtypes [37] (Fig. 6B), when compared to other molecular subtypes (p<0.00001).